Register free: ​ https://www.pharmtech.com/pt/drugdel
The drug delivery market continues to evolve with novel solutions being explored, beyond conventional oral dosage forms. The intranasal delivery route is frequently chosen for the local treatment of allergic rhinitis, nasal congestion and cold symptoms. However, intranasal delivery is emerging as an alternative route of systemic drug delivery for a variety of indications such as migraine, seizures, breakthrough pain and opioid overdose and more.
Join this webinar to learn about the challenges, opportunities, and advantages of intranasal drug delivery. An overview of the anatomy and physiology of the nasal cavity will provide an appreciation of the rationale for intranasal drug delivery, and how this influences key product development considerations. Experts will also discuss the utility of physiological-based pharmacokinetic (PBPK) modeling and simulation, and assessment of API physicochemical properties as predictors of the extent of systemic absorption following intranasal administration. The complex interplay between product attributes, drug exposure and manufacturing processes will also be addressed.
Learn about the challenges and opportunities of intranasal drug delivery and why it is drawing increasing interest as a route of administration
Understand how PBPK modeling tools can be used to predict drug absorption after intranasal administration and help guide formulation development
Gain insight into intranasal drug product formulation design and optimization considerations to ensure safe and effective in vivo performance, and manufacturability
This webinar will appeal to individuals working in:
Consultants for Drug Development
Jan Neelissen, PhD
Associate Director, DMPK Advisory Services
Samiran De, PhD
Thursday, November 18, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Sponsor: Catalent
Register free: https://www.pharmtech.com/pt/drugdel